FR2479228A1 - CEPHAPIRINE SALTS WITH AMINO ACIDS - Google Patents
CEPHAPIRINE SALTS WITH AMINO ACIDS Download PDFInfo
- Publication number
- FR2479228A1 FR2479228A1 FR8106002A FR8106002A FR2479228A1 FR 2479228 A1 FR2479228 A1 FR 2479228A1 FR 8106002 A FR8106002 A FR 8106002A FR 8106002 A FR8106002 A FR 8106002A FR 2479228 A1 FR2479228 A1 FR 2479228A1
- Authority
- FR
- France
- Prior art keywords
- cephapirin
- cephapirine
- salt
- cooh
- arginine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
Abstract
SELS DE CEPHAPIRINE AVEC UN AMINO-ACIDE SELECTIONNE DANS LE GROUPE COMPOSE DE LA L-LYSINE, LA L-ARGININE ET L'ACETYLCYSTEINE. CES SELS SONT OBTENUS EN FAISANT REAGIR UNE SOLUTION AQUEUSE DE CEPHAPIRINE AVEC UNE SOLUTION AQUEUSE D'UN AMINO-ACIDE OU SON DERIVE, SELECTIONNE DANS LE GROUPE COMPOSE DE LA L-LYSINE, LA L-ARGININE ET L'ACETYLCYSTEINE. POUR ISOLER LE SEL, LA SOLUTION AQUEUSE EST SOUMISE A LA LYOPHILISATION.SALTS OF CEPHAPIRINE WITH AN AMINO ACID SELECTED FROM THE GROUP CONSISTING OF L-LYSINE, L-ARGININE AND ACETYLCYSTEINE. THESE SALTS ARE OBTAINED BY REACTING AN AQUEOUS SOLUTION OF CEPHAPIRINE WITH AN AQUEOUS SOLUTION OF AN AMINO ACID OR ITS DERIVATIVE, SELECTED FROM THE GROUP CONSISTING OF L-LYSINE, L-ARGININE AND ACETYLCYSTEINE. TO ISOLATE THE SALT, THE AQUEOUS SOLUTION IS SUBJECT TO LYOPHILIZATION.
Description
L'invention se rapporte à de nouveaux sels de céphapirine avec des amino-The invention relates to novel cephapirin salts with amino
acides, ces sels ayant uneacids, these salts having a
activité antibiotique. La céphapirine est un antibioti- antibiotic activity. Cephapirin is an antibiotic
que bien connu, décrit dans le brevet américain No 3 422 100 et la demande de brevet japonais publiée as well known, described in US Patent No. 3,422,100 and published Japanese patent application
sous le No 44-26107.under No. 44-26107.
La céphapirine est habituellement administrée Cephapirin is usually administered
par voie parentérale sous la forme de son sel de sodium. parenterally in the form of its sodium salt.
Il est bien connu que les sels de sodium de ce It is well known that the sodium salts of this
type d'antibiotique et, en particulier, de la céphapiri- type of antibiotic and, in particular, cephapirin
ne, sont d'administration douloureuse par injection. no, are painful administration by injection.
L'invention se propose de fournir de nouveaux sels de céphapirine qui sont injectables sans induire de The invention proposes to provide new cephapirin salts which are injectable without inducing
réaction douloureuse lorsqu'on les administre. painful reaction when administered.
Elle concerne encore des sels de céphapirine qui accroissent l'absorption de la substance antibiotique et It also relates to cephapirin salts which increase the absorption of the antibiotic substance and
qui, lorsqu'ils sont absorbés par l'organisme, sont capa- which, when absorbed by the organism, are capable of
ble de joindre à l'activité antibiotique propre à la céphapirine leur propre activité spécifique, qui peut the cephapirin-specific antibiotic activity of their own specific activity, which may be
avoir un certain intérêt du point de vue pharmacologique. have some interest from a pharmacological point of view.
Ces résultats sont obtenus par salification de la céphapirine avec un amino-acide sélectionné dans le These results are obtained by salification of cephapirin with an amino acid selected from
groupe composé de la L-lysine, la L-arginine et l.acétyl- group consisting of L-lysine, L-arginine and acetyl-
cystéine. Pour obtenir cette salification, on fait réagir la céphapirine en solution aqueuse et à la température ambiante avec une solution aqueuse d'un amino-acide ou de son dérivé, sélectionné dans le groupe composé de la L-lysine, la L-arginine et l'acétylcistéine, le sel de cysteine. To obtain this salification, cephapirin is reacted in aqueous solution and at room temperature with an aqueous solution of an amino acid or its derivative, selected from the group consisting of L-lysine, L-arginine and l-arginine. acetylcistine, the salt of
céphapirine étant isolé de la solution aqueuse par lyo- cephapirin being isolated from the aqueous solution by
philisation.philisation.
L'invention sera mieux comprise à l'aide de la The invention will be better understood using the
description ci-après d'un procédé de préparation des trois description below of a process for preparing the three
sels qui font l'objet de l'invention, donné à titre salts which are the subject of the invention, given as
d'exemple purement illustratif.purely illustrative example.
Exemple 1Example 1
Lysinate de céphapirine de formuleCephapirin Lysinate Formula
- S -CH -XH- S -CH -XH
oN CHP2COCH3oN CHP2COCH3
COQH. H2N-(CH2) 4-CH-COOHCOQH. H2N- (CH2) 4-CH-COOH
H2H2
On introduit dans un flacon de réaction de l'eau bidistillée (500 ml) et de la céphapirine sous la forme acide (42,3 g, 0,1 mole); on mesure le pH et on constate qu'il est à 3,5. On ajoute une solution aqueuse de base Llysine à 50 contenant 14,6 g (0,1 mole) de base L-lysine; le mélange est maintenu sous agitation pendant 1 heure à 0 C. La dissolution complète est obtenue et le pH est élevé à 8. On ajoute du carbone décolorant (1,5 g) à la solution obtenue, que l'on filtre à travers des plaques de filtrage, et que l'on verse dans une coupelle Two-distilled water (500 ml) and cephapirin in the acid form (42.3 g, 0.1 mole) were added to a reaction flask; the pH is measured and it is found that it is at 3.5. A 50 Lysine aqueous base solution containing 14.6 g (0.1 mole) of L-lysine base is added; the mixture is stirred for 1 hour at 0 C. Complete dissolution is obtained and the pH is raised to 8. Bleaching carbon (1.5 g) is added to the resulting solution, which is filtered through filters. filter plates, and poured into a cup
jusqu'à obtenir une couche de 1 cm d'épaisseur. La solu- until you get a 1 cm thick layer. The solution
tion est alors congelée à -40 C et lyophilisée. Après 24 heures, la matière obtenue est enlevée et tamisée. On The mixture is then frozen at -40 ° C. and freeze-dried. After 24 hours, the resulting material is removed and sieved. We
obtient du lysinate de céphapirine (54 g). obtains cephapirine lysinate (54 g).
KF: 1,5%KF: 1.5%
TLC: produit unique Z- 7D (c = 1, H20: + 127 TLC: single product Z-7D (c = 1, H20: + 127
Titre microbiologique = 730 mcg/mg comme la céphapi- Microbiological titre = 730 mcg / mg as cephapid
rine sous la forme d'acide.in the form of acid.
- 3 -- 3 -
Exemple 2Example 2
Sel d'arginine de céphapirine ayant la formule Cephapirine arginine salt having the formula
N 5"-S-CH2- CO-NHN 5 "-S-CH 2 -CO-NH
CH2OCOCH3CH2OCOCH3
COOH. H2N\ (C H2COOH. H2N \ (C H2
C-NH-(CH 2)3-H-COOHC-NH- (CH 2) 3 -H-COOH
NH On introduit dans un flacon de réaction à 0 C, de l'eau bidistillée (450 ml) et de la céphapirine sous A double-distilled water (450 ml) and cephapirin were added to a reaction flask at 0 ° C.
la forme d'acide (42,3 g, 0,1 mole); le pH est de 3,5. the acid form (42.3 g, 0.1 mole); the pH is 3.5.
On ajoute à 0 C, une solution aqueuse à 10% de At 0 ° C., a 10% aqueous solution of
L-arginine (210 ml) contenant 21 g de L-arginine. L-arginine (210 ml) containing 21 g of L-arginine.
Le mélange de réaction est maintenu à 0 C pen- The reaction mixture is maintained at 0 C
dant 30 minutes; le pH est élevé à 8,5. On ajoute du car- 30 minutes; the pH is raised to 8.5. We add car-
bone décolorant (5 g) à la solution obtenue, qui est filtrée à travers des plaques de filtrage et versée dans bleaching bone (5 g) to the resulting solution, which is filtered through filter plates and poured into
une coupelle jusqu'à obtenir une couche de 1 cm d'épais- cup until a layer of 1 cm thick is
seur. Après pré-congélation à -45 C, on commence la lyo- sor. After pre-freezing at -45 C, we begin the
philisation. Elle se termine après 24 heures, la matière obtenue étant enlevée et tamisée; on obtient du sel philisation. It ends after 24 hours, the material obtained being removed and sieved; we get salt
d'arginine de céphapirine (55 g).arginine of cephapirin (55 g).
KF: 1,2%KF: 1.2%
TLC: produit simple Zq7D (c = 1, H20): + 120 TLC: simple product Zq7D (c = 1, H20): + 120
Titre microbiologique: 687 mcg/g comme la céphapi- Microbiological titre: 687 mcg / g, like cephapins
rine sous la forme d'acide.in the form of acid.
- 4 -- 4 -
Exemple 3Example 3
Acétylcystéinate de céphapirine ayant la formule Cephapirin acetylcysteate having the formula
HS -C2 -CH-COO. >-S -CHH2-CO-NH H2 3 HS -C2 -CH-COO. > -S-CHH2-CO-NH H2 3
NH-COCH3 0NH-COCH3 0
COOH On introduit dans un flacon de réaction de l'eau (500 ml) et de la céphapirine sous la forme d'acide (42, g 0,1 mole). Après refroidissement à 0 C, on ajoute COOH Water (500 ml) and cephapirin in the form of acid (42.0 g 0.1 mol) are introduced into a reaction flask. After cooling to 0 C, add
une solution aqueuse contenant 16,3 g (0,1 mole) d'acétyl- an aqueous solution containing 16.3 g (0.1 mol) of acetyl
cistéine. La dissolution complète est obtenue; le pH cor- cistéine. Complete dissolution is obtained; the correct pH
respondant est 2,1. On laisse le mélange réagir pendant 1 heure; on ajoute alors 3 g de carbone. La solution obtenue est filtrée à travers des plaques de filtrage, versée dans une coupelle jusqu'à obtenir une couche de respondent is 2.1. The mixture is allowed to react for 1 hour; 3 g of carbon are then added. The solution obtained is filtered through filter plates, poured into a cup until a layer of
1 cm d'épaisseur et soumise à une pré-congélation. 1 cm thick and pre-frozen.
A -40 C, la solution est complètement congelée et est lyophilisée. La lyophilisation est terminée en 36 heures. La matière obtenue est tamisée et on obtient At -40 ° C, the solution is completely frozen and lyophilized. Lyophilization is complete in 36 hours. The obtained material is sieved and we obtain
de l'acétylcystéinate de céphapirine (55,6 g). cephapirin acetylcysteate (55.6 g).
KF: 1%KF: 1%
TLC: produit unique t-D (c: 1, H20): + 118 Titre microbiologique: 707 mcg/mg comme la TLC: single product t-D (c: 1, H20): + 118 microbiological title: 707 mcg / mg as the
céphapirine sous la forme d'acide.cephapirin in the form of acid.
- 5 -- 5 -
Claims (5)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21097/80A IT1141406B (en) | 1980-04-01 | 1980-04-01 | SALTS OF CEPHAPIRINE WITH AMINO ACIDS |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2479228A1 true FR2479228A1 (en) | 1981-10-02 |
FR2479228B1 FR2479228B1 (en) | 1985-04-26 |
Family
ID=11176688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8106002A Granted FR2479228A1 (en) | 1980-04-01 | 1981-03-25 | CEPHAPIRINE SALTS WITH AMINO ACIDS |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS56152490A (en) |
CA (1) | CA1133471A (en) |
CH (1) | CH651050A5 (en) |
DE (1) | DE3110190A1 (en) |
FR (1) | FR2479228A1 (en) |
GB (1) | GB2072675B (en) |
IL (1) | IL62254A (en) |
IT (1) | IT1141406B (en) |
NL (1) | NL8101274A (en) |
YU (1) | YU82781A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1242699A (en) * | 1985-02-01 | 1988-10-04 | Bristol-Myers Company | Cefbuperazone and derivatives thereof |
US6566401B2 (en) * | 2001-03-30 | 2003-05-20 | The Board Of Trustees Of The Leland Stanford Junior University | N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity |
CN102351885B (en) * | 2011-08-19 | 2012-08-22 | 深圳立健药业有限公司 | Method for preparing cefuroxime-L-arginine hydrate |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1580837A (en) * | 1967-01-05 | 1969-09-12 | ||
FR2220533A1 (en) * | 1973-03-08 | 1974-10-04 | Gallardo Antonio Sa |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5089517A (en) * | 1973-12-18 | 1975-07-18 | ||
JPS51125714A (en) * | 1975-02-19 | 1976-11-02 | Banyu Pharmaceut Co Ltd | A process for preparing salts of an antibacterial compound |
JPS557434A (en) * | 1978-06-30 | 1980-01-19 | Matsushita Electric Works Ltd | Preparation of woody cement board |
-
1980
- 1980-04-01 IT IT21097/80A patent/IT1141406B/en active
-
1981
- 1981-03-02 IL IL62254A patent/IL62254A/en unknown
- 1981-03-09 CH CH1586/81A patent/CH651050A5/en not_active IP Right Cessation
- 1981-03-16 NL NL8101274A patent/NL8101274A/en not_active Application Discontinuation
- 1981-03-17 DE DE19813110190 patent/DE3110190A1/en not_active Withdrawn
- 1981-03-25 FR FR8106002A patent/FR2479228A1/en active Granted
- 1981-03-27 JP JP4421681A patent/JPS56152490A/en active Pending
- 1981-03-30 YU YU00827/81A patent/YU82781A/en unknown
- 1981-03-31 GB GB8109978A patent/GB2072675B/en not_active Expired
- 1981-03-31 CA CA374,263A patent/CA1133471A/en not_active Expired
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1580837A (en) * | 1967-01-05 | 1969-09-12 | ||
FR2220533A1 (en) * | 1973-03-08 | 1974-10-04 | Gallardo Antonio Sa |
Also Published As
Publication number | Publication date |
---|---|
GB2072675A (en) | 1981-10-07 |
DE3110190A1 (en) | 1982-02-18 |
IT8021097A0 (en) | 1980-04-01 |
CA1133471A (en) | 1982-10-12 |
YU82781A (en) | 1983-09-30 |
IL62254A (en) | 1984-09-30 |
IL62254A0 (en) | 1981-05-20 |
CH651050A5 (en) | 1985-08-30 |
GB2072675B (en) | 1983-12-07 |
FR2479228B1 (en) | 1985-04-26 |
IT1141406B (en) | 1986-10-01 |
JPS56152490A (en) | 1981-11-26 |
NL8101274A (en) | 1981-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2623498A1 (en) | NOVEL ENANTIOMERIC COMPOUNDS DERIVED FROM AMINO ACIDS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC APPLICATIONS | |
JPS581105B2 (en) | Optically active amino acid-mandelic acid complex and method for producing the same | |
Myers et al. | A one-step synthesis of pseudoephedrine glycinamide, a versatile precursor for the synthesis of α-amino acids | |
FR2479228A1 (en) | CEPHAPIRINE SALTS WITH AMINO ACIDS | |
EP0530887A1 (en) | Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases | |
BE1011326A5 (en) | Process for preparing a crystalline form therapeutically active and glucosamine sulphate and glucosamine sulphate obtained. | |
FR2591226A1 (en) | AROMATIC SULFONIC ACID SALTS OF NE-TRIFLUOROACETYL-L-LYSYL-L-PROLINE | |
WO2000071526A1 (en) | Gadolinium complex tetramides and use in medical imaging | |
SU504491A3 (en) | The method of obtaining derivatives of penicillin | |
FR2504526A1 (en) | AMIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND ANTI-COMPLEMENT AGENTS CONTAINING THEM | |
EP0279716B1 (en) | Process for the n-omega-trifluoroacetylation of alpha, omega-saturated aliphatic diamino-monocarboxylic acids | |
FR2777889A1 (en) | New octahydro-6,10-dioxo-6H-pyridazino(1,2-a)-1,2-diazepin-1-carboxy lic acid derivatives useful as intermediates for pharmaceuticals | |
US3488379A (en) | Optically active salt complexes of carnitine nitrile hydroxide and n-acryl glutamic acids and their preparation | |
US3637804A (en) | Phenylalanine derivatives and preparation thereof | |
WO1983000146A1 (en) | New derivatives of dipeptides, method for the preparation thereof and utilization thereof as drugs | |
FR2479226A1 (en) | CEPHADROXYL SALTS WITH AMINO ACIDS | |
Gaudry | Study on the synthesis of valine by the Strecker method | |
CH410900A (en) | Process for preparing new nitrogen mustards | |
EP0092380B1 (en) | Antiallergic 4h-furo(3,2-b)indoles and their production | |
JP3400105B2 (en) | Optically active sulfonic acid derivative and production method thereof | |
FR2478629A1 (en) | 2-CYANO-ETHYL-2- (N-BENZOYLAMINO) ALKANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION | |
CA1098911A (en) | N-(1'-ethyl 2'-oxo 5'-pyrrolidinyl methyl) benzamids, preparation process and use as behaviour modifiers | |
SU939443A1 (en) | Process for producing 2-phenyl-4(beta-carbmethoxypropionyl) oxazolinone-5 | |
JPS6134424B2 (en) | ||
SE8205563D0 (en) | PROCESS FOR THE PREPARATION OF VINCAMINIC ACID ESTERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |